<DOC>
	<DOC>NCT00503516</DOC>
	<brief_summary>The purpose of this study is to demonstrate the efficacy of megestrol acetate in the gain of body weight in patients with primary or mixed Dementia with a weight loss.</brief_summary>
	<brief_title>Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia Patients</brief_title>
	<detailed_description>In all geriatric patients with dementia it was prove a weight loss independently if they are institutionalized or not.There are some previous studies that indicates the effect of the megestrol acetate in the weight gain of patients with cachexia-anorexia related with neoplasia. It seems that the mechanism of development could be the same between these patients and patients with dementia. It was described an important role of a group of cytokines ( Il-6, leptin, neuropeptide Y, TNFalfa) in the development of this nutritional alteration. Some previous pilots studies indicates that megestrol acetate has and effect in geriatric and dementia patients with a weight loss of at least 5% in the last 6 months.</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Megestrol Acetate</mesh_term>
	<criteria>Patients diagnosed of primary or mixed dementia (CIE 10criteria) Weihgt loss &gt;5% of habitual weight in the last 6 months and proteiccaloric malnutrition (MNA &lt;17) Outpatients Patients that accept the participation in the study Vascular pure Dementia and secondary dementias( vascular dementia, Parkinson disease,etc) Dementia in a terminal phase: category of FAST 7c in the Reisber scale Concomitant treatment with steroids, androgens or other drugs with progestagens Weight loss secondary to neoplasia</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>weight loss, appetite, dementia, megestrol acetate</keyword>
</DOC>